Significant Ownership of Propel Bio Management, LLC

Signature - Title
Leen Kawas - Managing Member
Location
Los Angeles, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Propel Bio Management, LLC.

Notify me when Propel Bio Management, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Propel Bio Management, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MIST Milestone Pharmaceuticals Inc. Common Stock 9.9% $21,001,011 8,861,186 Propel Bio Management, LLC 11 Jul 2025
APLT Applied Therapeutics, Inc. Common Stock 4.2% $1,564,002 6,015,394 Propel Bio Management, LLC 29 Dec 2025

Schedules 13D/G Reported by Propel Bio Management, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.